Skip to main content
Clinical Trials/NCT02829645
NCT02829645
Unknown
Not Applicable

Evaluation of the Clinical, Neuropsychological and Psychosocial Situation of Patient With Eating Disorders.

University Hospital, Montpellier0 sites370 target enrollmentFebruary 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Eating Disorders
Sponsor
University Hospital, Montpellier
Enrollment
370
Primary Endpoint
Frequency of remission rates
Last Updated
9 years ago

Overview

Brief Summary

Eating disorders (ED) are serious mental illnesses with an excess mortality and many affects in the quality of life of patients and thier relatives. Management of ED is very difficult : the prognosis remains relatively poor both in terms of remission rate and quality of life. In this context, the contribution of new strategies for pathophysiological exploration and the development of therapeutic options are crucial.

In this project the investigators aim to constitute un cohort of patients from a day unit specialized in the management of ED. A prospective follow-up will be offered to patients to assess their clinical and psycho-social evolution. The overall objective is to identify which factors are prognostic of clinical improvement of the ED. We also want to better characterize patients that will migrate from diagnosis to another.

Detailed Description

The investigators propose to assess, with a cohort of patients with ED the prognostic value of cognitive abnormalities associated with ED (cognitive flexibility and central coherence) They will recruit 370 patients suffering from a current ED (anorexia, bulimia, binge eating disorder, Eating disorder not otherwise specified). Each patient will be reassessed every year for 3 years.

Registry
clinicaltrials.gov
Start Date
February 2012
End Date
October 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Frequency of remission rates

Time Frame: At the inclusion and at 12, 24 and 36 months

study of remission rates frequency at 12 months depending on the Brixton score assessed at baseline (assessment of cognitive flexibility). Remission is defined as disappearance of ED Diagnostic and Statistical Manual (DSM) criteria.

Secondary Outcomes

  • score to another neuropsychological test (Iowa gambling task (IGT)(At the inclusion and at 12, 24 and 36 months)
  • scores to another neuropsychological test : D2 test of attention(At the inclusion and at 12, 24 and 36 months)
  • scores to another other neuropsychological test : Rey-Osterrieth complex figure(At the inclusion and at 12, 24 and 36 months)

Similar Trials